Economy News
Markets, macro and movers — curated.
Thursday Market Close: Paramount-WBD Merger Faces State Lawsuit, Costco Cools, New Housing Data
State attorneys general may sue to block the $110B Paramount-WBD merger; Costco sales cool, housing softens, and Delta and SK Hynix loom.
Why Gold and Silver Fall First and Win Later in the Coming Reset
A market analyst explains why precious metals drop during a forced-selling panic before capital preservation drives them higher in a reset bigger than 2008.
SK Hynix's Blockbuster IPO and the Memory Squeeze Powering AI
SK Hynix's IPO could raise up to $28 billion as surging AI demand turns memory chips into a key data center asset.
Salesforce Downgrade, Pepsi's Miss, and Levi's Beat: Three Stocks in Motion
KeyBank downgrades Salesforce over AI payoff doubts, Pepsi misses on earnings, and Levi's beats and raises guidance.
Spotify's Sour Note: A 30% Slide and a Neutral Options Setup
Spotify shares are down 32.8% year-over-year; a technical read of support, momentum, and a neutral iron condor trade for August.
Between War and Ceasefire: Markets Shrug Off Iran and Refocus on Earnings
With U.S.-Iran tension unresolved but crude staying below $70, markets are turning attention back to strong earnings and a steady labor market.
Iran Strikes Lose Their Market Bite as Chips and Memory Drive the Tape
Geopolitical shock is fading from US markets while chip stocks, the SK Hynix IPO, Micron, and Fed inflation worries take over.
Ceasefire Fragility, Fed Risk, and a High Earnings Bar
A market read on the U.S.-Iran flare-up, the risk of a Fed rate-hiking cycle, rising yields, and a demanding earnings season ahead.
Rick Rule: Fear-Priced Gold Miners, the ETF Run Risk, and a Soft Second Half
Why fear has mispriced gold miners, how junk-bond ETFs could trigger a run without an FDIC backstop, and where value sits in a soft 2026.
Oil Surges on Iran Threats as Money Rotates From Korea Into Chinese Tech
Oil jumps over 5% on renewed US-Iran tensions while capital rotates out of South Korean chips into Chinese tech names like Alibaba.
The Bull Case for Alphabet: Owning the Full AI Stack
Why Alphabet remains a buy: it owns the full AI stack, cloud is booming, antitrust risk faded, but capex is the variable to watch.
Strategy Sells Bitcoin: What the Shift Signals for MSTR and the Four-Year Cycle
Strategy's Bitcoin sales, its pivot to capital management, and the technical levels that decide whether crypto is pausing or correcting.
Crypto's Regulatory Moment: The Clarity Act Deadline and the Money Moving Quietly
The Clarity Act faces an August 7th deadline while Bitcoin ETFs buy the dip and institutions tokenize on-chain despite market weakness.
Why Gold's 25% Crash Is a Buying Opportunity, Not the End of the Bull Market
A commodities analyst argues gold's 25% drop from $5,355 was forced dollar-selling for oil, not failed fundamentals, and reaffirms a $10,000 target.
Apple's $30B Broadcom Deal and Two Ways to Trade the Stock Into Earnings
Apple's $30B Broadcom chip deal, its low capex versus hyperscalers, and two contrasting options trades ahead of July 30 earnings.
Why Pepsi Looks Cheap in a Beverage Sector Squeezed by GLP-1s and MAHA
A read on why Pepsi is the most attractive consumer-staples stock, plus a covered-call trade ahead of its earnings, in a beverage sector pressured by GLP-1s and MAHA.
The Big Three: Mastercard, Valero, and Bullish Under the Tape
A fundamental and technical read on Mastercard, Valero, and Bullish, framed by a semiconductor-led first half and a healthy rotation.
Tech's Bias to the Upside Amid Rampant Single-Stock AI Volatility
Why AI and chip names swing violently day to day, what the 50-day bounce signals, and how capex cuts could ripple through the whole market.
Apple's $30B Broadcom Chip Deal Lands as a Broadcom Win
Apple's $30B Broadcom chip pact reads as a Broadcom win while shares stay muted, and a trader fades the fear across a dip-buying market.
Kevin Mahn on Hormuz Risk, a Cautious Fed, and the "AIR" Basket Beating the Mag 7
Geopolitical risk over Hormuz drives oil and Fed uncertainty, while a seven-name AI basket and small-cap biotech offer growth.